ABCDx is a company headquartered in Geneva, Switzerland that discovers and develops diagnostic tools transforming care for patients with brain injuries. ABCDx’s devices help the healthcare professionals in the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury from stroke and trauma to post-injury complications and patient outcome. ABCDx is pioneering the ability to decode the chemical messages of the brain (brain biomarkers) so that brain injury can be detected in a drop of blood from a finger prick, allowing the diagnosis at the admission of the emergency department, before hospitalization or even directly on the field where the injury occurred.